Amid 23andMe's bankruptcy, these biobanks promise more transparency and representation

Amid 23andMe's bankruptcy, these biobanks promise more transparency and representation

Amid 23andMe's bankruptcy, these biobanks promise more transparency and representation


Only 14% of DNA used in medical research is from people with non-European ancestry. Two nonprofits want to change that.

Related Post

Leave a Reply

Your email address will not be published. Required fields are marked *